Meliha Ekinci is a research assistant at Radiopharmacy Department, Ege University, Turkey. Her main research interest focuses on radiolabeling and evaluating newly developed radiopharmaceuticals for diagnosis of different cancer types, especially breast, lung and bone cancers, and novel drug delivery systems (nanoparticles, microemulsions, etc.). She has published over 15 research papers and review articles and over 30 conference presentations. She has been serving as an editorial board member and a reviewer of international journals. She has completed 6 scientific research projects and she is currently working on 2 projects about new radiopharmaceuticals. She has 50 citations up to now.

Novel drug delivery systems, Nanoradiopharmaceuticals, Cancer diagnosis, Radiolabeling, Nanotechnology.

Dr. Bimal Roy Krishna is a professor and Director of pharmacology for Touro University, College of Osteopathic medicine in Nevada. He is a Doctor of philosophy and is a member of a number of organizations including fellow American college of clinical pharmacology.

He has contributed to numerous publications and is a member of a number of organizations including Fellow-American College of Clinical Pharmacology.